- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01715389
Evaluation of a Shared Decision Making Portal for Pediatric Asthma
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- The Children's Hospital of Philadelphia
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Parents/legal guardians of children aged 6-12 with persistent asthma, currently receiving chronic maintenance therapy, cared for at a study practice, with consistent access to a computer with an internet connection where they feel comfortable accessing MyChart (patient portal)
- Clinician at study site
Exclusion Criteria:
- parents non-english speaking
- child's primary care provider at the time of enrollment is a pediatric resident
- not meeting inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Parents in the intervention group will use the MyAsthma Patient Portal to receive enhanced educational information on asthma and its treatment, identify concerns and goals related to asthma treatment, track progress toward goals and management of concerns monthly, and track asthma symptoms monthly. Clinicians seeing intervention families at office visits will have access to information from the portal including concerns, goals, progress toward goals, and tracking of asthma symptoms. |
Parents in the intervention group will use the MyAsthma Patient Portal to receive enhanced educational information on asthma and its treatment, identify concerns and goals related to asthma treatment, track progress toward goals and management of concerns monthly, and track asthma symptoms monthly. Clinicians seeing intervention families at office visits will have access to information from the portal including concerns, goals, progress toward goals, and tracking of asthma symptoms. |
No Intervention: Control
The control group will be signed up for MyChart but not use the MyAsthma Patient Portal.
This group will be referred to asthma educational content on the CHOP website, complete study measures and otherwise, receive standard care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability of the intervention to parents and clinicians
Time Frame: 24 months
|
Parents and clinicians will be asked a series of open-ended questions regarding themes including satisfaction, acceptability and unintended consequences of using the portal for intervention subjects and using MyChart in general for control subjects.
Subjects will also be asked a series of Likert-scaled questions related to satisfaction.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Shared decision making
Time Frame: Baseline
|
Joint participation in decision-making will be measured by the Observing Parent Involvement (OPTION) scale.
|
Baseline
|
Parent Activation
Time Frame: 0 months, 3 months, 6 months
|
Parent activation will be measured by the Parent Patient Activation Measure (PPAM).
|
0 months, 3 months, 6 months
|
Goal Attainment
Time Frame: 0 months, 3 months, 6 months then Monthly
|
Parents will identify one or more goals at the study start.
Progress toward the goal(s) will be assessed at 3 and 6 month follow-up using Likert-scaled items for the control group, and monthly through use of the portal for the intervention group.
|
0 months, 3 months, 6 months then Monthly
|
Asthma-Related Quality of Life
Time Frame: 0 months, 6 months
|
Asthma-related quality of life will be measured using The Integrated Therapeutics Group Child Asthma Short Form (ITG-CASF)
|
0 months, 6 months
|
Asthma Control
Time Frame: 0 months, 6 months
|
Asthma control will be assessed using the Pediatric Asthma Control Tool (PACT)
|
0 months, 6 months
|
Asthma-related Utilization
Time Frame: 3 months, 6 months
|
Utilization will be measured by parent report and chart review by the research team of the following: Any primary care or subspecialty outpatient encounters relevant to asthma care, asthma-specific acute primary care visits or Urgent Care Center visits, asthma-specific Emergency Room visits, asthma-specific hospital admissions. |
3 months, 6 months
|
Asthma Medication Adherence/Receipt
Time Frame: 6 months
|
Prescribed medications for the treatment and management of asthma Type and number of prescriptions for asthma
|
6 months
|
Feasibility of Recruitment
Time Frame: 24 months
|
The feasibility of recruitment will be assessed by examining the proportion of all families contacted who meet enrollment criteria and the proportion of families meeting enrollment criteria who enroll.
|
24 months
|
Feasibility of Follow-up
Time Frame: 24 months
|
The feasibility of follow-up will be assessed by the proportion of enrolled families who complete each study measure.
|
24 months
|
Feasibility of Portal Use
Time Frame: 24 months
|
The feasibility of portal use will be assessed by the level of research team/other outside support needed.
|
24 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alexander G Fiks, MD, MSCF, Children's Hospital of Philadelphia
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-009407
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Vanderbilt University Medical CenterNot yet recruitingAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SingHealth PolyclinicsNot yet recruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma Chronic
-
Johann Wolfgang Goethe University HospitalCompleted
-
Universita di VeronaCompleted
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
-
Forest LaboratoriesCompleted
-
Brunel UniversityKarolinska InstitutetUnknown
-
Value Outcomes Ltd.AstraZenecaCompletedAsthma, Bronchial | Bronchial Asthma | Asthma Chronic | Asthma; EosinophilicCzechia
Clinical Trials on MyAsthma Patient Portal
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ); American Academy of Pediatrics and other collaboratorsCompletedAsthmaUnited States
-
University of AmsterdamCompletedDeprescribing | Fall | Fall Injury | Fall Patients | Accidental FallNetherlands
-
University of California, San FranciscoCompleted
-
Karthik TennankoreCompletedPeritoneal Dialysis | Hemodialysis, HomeCanada
-
Madigan Army Medical CenterTelemedicine & Advanced Technology Research Center; Analytics4Medicine, Inc.Unknown
-
University of PennsylvaniaCompletedCardiovascular Diseases | HypertensionUnited States
-
my mhealth LtdBradford Teaching Hospitals NHS Foundation TrustWithdrawn
-
Yale UniversityNot yet recruiting
-
Geisinger ClinicCompletedHealth BehaviorUnited States
-
Vanderbilt University Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Active, not recruitingDiabetes MellitusUnited States